Colorectal Cancer

>

Latest News

"Our preliminary results showed that the efficacy of fruquintinib combined with capecitabine is promising with well tolerance as maintenance therapy in RAS/BRAF wild-type mCRC,” according to lead study author, Kai Ou.
Fruquintinib Combo Shows Early Activity in RAS/BRAF+ Metastatic CRC

May 9th 2025

At the time of analysis, the median progression-free survival was not reached with fruquintinib plus capecitabine in a phase 1/2 trial.

Patients with MSS tumors diagnosed with metastatic CRC did not experience enhanced OS outcomes with frontline ICI therapy compared with chemotherapy.
Frontline ICI Therapy Confers OS Benefit in MSI-H Metastatic CRC

May 8th 2025

Sotorasib at 960 mg Plus Panitumumab Emerges as SOC in KRAS G12C+ mCRC
Sotorasib at 960 mg Plus Panitumumab Emerges as SOC in KRAS G12C+ mCRC

May 1st 2025

Fruquintinib Combo Exhibits Manageable Safety Profile in Pretreated mCRC
Fruquintinib Combo Exhibits Manageable Safety Profile in Pretreated mCRC

April 22nd 2025

Although the overall incidence of colorectal adenocarcinoma is decreasing, the reduction is primarily associated with patients 55 years and older.
Pancreatic/Colorectal Adenocarcinoma Rates Have Increased in Young Adults

April 15th 2025

Latest CME Events & Activities

Community Practice Connections™: 9th Annual School of Gastrointestinal Oncology®

View More

BURST CME™: Illuminating the Crossroads of Precision Medicine and Targeted Treatment Options in Metastatic CRC

View More

Go To PER in Chicago

May 30, 2025 - June 3, 2025

Register Now!

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

Community Practice Connections™: 14th Asia-Pacific Primary Liver Cancer Expert Meeting

View More

PER® Liver Cancer Tumor Board: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today… and Tomorrow?

View More

Show Me the Data™: Bridging Clinical Gaps Along the Continuum From Resectable, Early Stage to Advanced Gastric/Gastroesophageal Junction Cancers

View More

<1
...
373839404142>